Over-the-scope clip system: A review of 1517 cases over 9 years.


Journal

Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 14 06 2018
revised: 12 07 2018
accepted: 24 07 2018
pubmed: 3 8 2018
medline: 6 5 2019
entrez: 3 8 2018
Statut: ppublish

Résumé

Rescue therapy for gastrointestinal (GI) refractory bleeding, perforation, and fistula has traditionally required surgical interventions owing to the limited performance of conventional endoscopic instruments and techniques. An innovative clipping system, the over-the-scope clip (OTSC), may play an important role in rescue therapy. This innovative device is proposed as the final option in endoscopic treatment. The device presents several advantages including having a powerful sewing force for closure of GI defects using a simple mechanism and also having an innovative feature, whereby a large defect and fistula can be sealed using accessory forceps. Consequently, it is able to provide outstanding clinical effects for rescue therapy. This review clarifies the current status and limitations of OTSC according to different indications of GI refractory disease, including refractory bleeding, perforation, fistula, and anastomotic dehiscence. An extensive literature search identified studies reported 10 or more cases in which the OTSC system was applied. A total of 1517 cases described in 30 articles between 2010 and 2018 were retrieved. The clinical success rates and complications were calculated overall and for each indication. The average clinical success rate was 78% (n = 1517) overall, 85% for bleeding (n = 559), 85% (n = 351) for perforation, 52% (n = 388) for fistula, 66% (n = 97) for anastomotic dehiscence, and 95% (n = 122) for other conditions, respectively. The overall and severe OTSC-associated complications were 1.7% (n = 23) and 0.59% (n = 9), respectively. This review concludes that the OTSC system may serve as a safe and productive device for GI refractory diseases, albeit with limited success for fistula.

Identifiants

pubmed: 30069935
doi: 10.1111/jgh.14402
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-30

Informations de copyright

© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Auteurs

Hideki Kobara (H)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.

Hirohito Mori (H)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.

Noriko Nishiyama (N)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.

Shintaro Fujihara (S)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.

Keiichi Okano (K)

Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Takamatsu, Japan.

Yasuyuki Suzuki (Y)

Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Takamatsu, Japan.

Tsutomu Masaki (T)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH